The Mii Fund looks at skin innovation in a broad and holistic manner from pharma to digital, from med-tech to microbiome and cosmetics, from market need to market impact.
Vision:
To create a synergy between the best of Israeli life-science innovation and Japanese corporate culture and big pharma expertise.
Japan First:
Through the fund’s partnership with Maruho,
Japan’s preeminent leader in dermatology, the Mii Fund aims to bring Israeli innovation in dermatology and skin care to the Japanese market, in effect giving Japan first rights to next generation skin therapies.
Mii is seeking innovative skin-related technologies across all stages and categories with significant market impact potential.
MII invests in dermatology related technologies across different stages seed to growth – covering the pharma, biotech, medical device, digital health, and cosmetic sectors.
Eran Perry
Co-Founder & Managing Director
Dr. Doron Friedman
Co-Founder & Managing Director
Junichi Hamada
Co-Founder & Managing Director
Masanobu Ogawa
Co-Founder & Managing Director
Mr. Kenichi Owada
Member of Investment Committee
Dr. Alona Weiss
Senior Analyst
Limor Regev Yuzik
CFO
Dr. Doron Friedman,
Co-Founder &
Managing Director
Junichi Hamada,
Co-Founder &
Managing Director
Masanobu Ogawa,
Co-Founder &
Managing Director
Mr. Kenichi Owada
Member of Investment Committee
Dr. Alona Weiss
Senior Analyst
Limor Regev Yuzik
CFO
